Chandra Bhagat Pharma

Executive Summary

Chandra Bhagat Pharma Ltd. (CBC Pharma) is a well-established Indian pharmaceutical company founded in 1944, with a strong focus on oncology, cardiovascular, anti-infective, and hormone therapies. The company manufactures a broad portfolio of dosage forms including tablets, capsules, injectables, and lyophilized products at GMP-compliant facilities. Leveraging a robust cold-chain logistics network, CBC Pharma serves both regulated and semi-regulated markets worldwide. As a publicly traded company, it continues to expand its export footprint and product offerings, aiming to capitalize on growing global demand for affordable generic pharmaceuticals. With over eight decades of operational history, the company has built a reputation for quality manufacturing and reliable supply chains, positioning it as a steady player in the generic drug market.

Upcoming Catalysts (preview)

• Q4 2026Potential new product approvals in regulated markets (e.g., US FDA, EU)50% success
• H2 2026Expansion of manufacturing capacity or new facility commissioning70% success
• Q3 2026Strategic partnership or contract manufacturing agreement with global pharma40% success